MX2008002161A - Chimeric antibodies with new world primate regions. - Google Patents
Chimeric antibodies with new world primate regions.Info
- Publication number
- MX2008002161A MX2008002161A MX2008002161A MX2008002161A MX2008002161A MX 2008002161 A MX2008002161 A MX 2008002161A MX 2008002161 A MX2008002161 A MX 2008002161A MX 2008002161 A MX2008002161 A MX 2008002161A MX 2008002161 A MX2008002161 A MX 2008002161A
- Authority
- MX
- Mexico
- Prior art keywords
- regions
- new world
- chimeric antibodies
- world primate
- cdr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Abstract
The present invention provides a chimeric antibody or an antigen-binding portion thereof. The antigen-binding portion comprises at least two complementarity determining regions (CDR) and at least three framework regions, wherein at least one CDR is a New World primate CDR.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005904406A AU2005904406A0 (en) | 2005-08-15 | New World Antibodies | |
PCT/AU2006/001166 WO2007019621A1 (en) | 2005-08-15 | 2006-08-15 | Chimeric antibodies with new world primate regions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008002161A true MX2008002161A (en) | 2008-04-22 |
Family
ID=37757238
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008002161A MX2008002161A (en) | 2005-08-15 | 2006-08-15 | Chimeric antibodies with new world primate regions. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1945669A4 (en) |
JP (1) | JP2009504686A (en) |
KR (1) | KR20080068005A (en) |
CN (2) | CN101287762A (en) |
AU (1) | AU2006281981A1 (en) |
BR (2) | BRPI0614430A2 (en) |
CA (1) | CA2619245A1 (en) |
MX (1) | MX2008002161A (en) |
NO (1) | NO20080800L (en) |
NZ (1) | NZ565904A (en) |
RU (1) | RU2008110058A (en) |
WO (1) | WO2007019621A1 (en) |
ZA (2) | ZA200802246B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2575838A1 (en) | 2004-07-26 | 2006-03-30 | Biogen Idec Ma Inc. | Anti-cd154 antibodies |
CN101400703B (en) | 2006-02-01 | 2013-05-08 | 赛法隆澳大利亚控股有限公司 | Domain antibody construct |
JP5721951B2 (en) * | 2007-03-22 | 2015-05-20 | バイオジェン アイデック マサチューセッツ インコーポレイテッド | Binding proteins that specifically bind to CD154, including antibodies, antibody derivatives, and antibody fragments, and uses thereof |
WO2010017595A1 (en) * | 2008-08-14 | 2010-02-18 | Arana Therapeutics Limited | Variant domain antibodies |
RU2535034C2 (en) * | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Medication and method of preventing hiv infection, prevention and treatment of hiv-induced or hiv-associated diseases, including aids |
RU2535033C2 (en) * | 2010-08-06 | 2014-12-10 | Олег Ильич Эпштейн | Therapeutic agent and method for prevention of hiv infection and treatment of hiv-caused or hiv-associated diseases, including aids |
RU2577299C2 (en) * | 2011-07-04 | 2016-03-10 | Олег Ильич Эпштейн | Method for treating infectious diseases and complex medication for treatment of infectious diseases |
RU2521392C2 (en) * | 2010-08-06 | 2014-06-27 | Олег Ильич Эпштейн | Combined drug for treating viral infections and method of treating viral infections |
RU2516931C2 (en) * | 2010-08-06 | 2014-05-20 | Олег Ильич Эпштейн | Method and composition for preventing hiv infection, preventing and treating hiv-caused or hiv-associated diseases, including aids |
RU2517085C2 (en) * | 2010-08-06 | 2014-05-27 | Олег Ильич Эпштейн | Complex medication and method of preventing hiv infection, prevention and treatment of hiv-induced and hiv-associated diseases, including aids |
RU2502521C2 (en) * | 2010-08-06 | 2013-12-27 | Олег Ильич Эпштейн | Combined drug for treating bacterial infections and method of treating bacterial infections |
RU2519862C2 (en) * | 2010-08-06 | 2014-06-20 | Олег Ильич Эпштейн | Complex medication and method of prevention and treatment of infectious viral diseases |
RU2505312C2 (en) * | 2010-08-06 | 2014-01-27 | Олег Ильич Эпштейн | Combined therapeutic agent for treating various types of influenza |
RU2579262C1 (en) * | 2014-10-02 | 2016-04-10 | Мапикс Эс.Эй.Ар.Эл. | Medicinal agent for treating infectious diseases |
CL2015002152A1 (en) * | 2015-07-31 | 2016-06-03 | Pontificia Universidad Católica De Chile | Monoclonal antibodies specific for the human syncytial respiratory virus (vrsh) antigen, produced and secreted by cellular hybridomas, useful for the detection and diagnosis of infection caused by vrsh |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0605442B1 (en) * | 1991-07-25 | 2003-04-16 | Idec Pharmaceuticals Corporation | Recombinant antibodies for human therapy |
US6569431B2 (en) * | 2000-10-17 | 2003-05-27 | The Regents Of The University Of California | Recombinant antibody fragments as autoantibody antagonists |
US7235643B2 (en) * | 2000-11-07 | 2007-06-26 | Morphotek, Inc. | Antibodies and methods for generating genetically altered antibodies with high affinity |
CN1678634A (en) * | 2002-06-28 | 2005-10-05 | 多曼蒂斯有限公司 | Immunoglobulin single variable antigen combination area and its opposite constituent |
US20070212301A1 (en) * | 2003-11-07 | 2007-09-13 | Amgen, Inc. | Monkey Immunoglobulin Sequences |
-
2006
- 2006-08-15 CN CNA2006800381577A patent/CN101287762A/en active Pending
- 2006-08-15 CN CNA2006800382565A patent/CN101287763A/en active Pending
- 2006-08-15 EP EP06774813A patent/EP1945669A4/en not_active Withdrawn
- 2006-08-15 ZA ZA200802246A patent/ZA200802246B/en unknown
- 2006-08-15 BR BRPI0614430-6A patent/BRPI0614430A2/en not_active IP Right Cessation
- 2006-08-15 KR KR1020087006270A patent/KR20080068005A/en not_active Application Discontinuation
- 2006-08-15 WO PCT/AU2006/001166 patent/WO2007019621A1/en active Application Filing
- 2006-08-15 RU RU2008110058/13A patent/RU2008110058A/en not_active Application Discontinuation
- 2006-08-15 AU AU2006281981A patent/AU2006281981A1/en not_active Abandoned
- 2006-08-15 JP JP2008526323A patent/JP2009504686A/en active Pending
- 2006-08-15 CA CA002619245A patent/CA2619245A1/en not_active Abandoned
- 2006-08-15 MX MX2008002161A patent/MX2008002161A/en not_active Application Discontinuation
- 2006-08-15 ZA ZA200802247A patent/ZA200802247B/en unknown
- 2006-08-15 NZ NZ565904A patent/NZ565904A/en not_active IP Right Cessation
- 2006-08-15 BR BRPI0614867-0A patent/BRPI0614867A2/en not_active IP Right Cessation
-
2008
- 2008-02-14 NO NO20080800A patent/NO20080800L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1945669A4 (en) | 2009-07-22 |
WO2007019621A1 (en) | 2007-02-22 |
BRPI0614867A2 (en) | 2012-01-31 |
NZ565904A (en) | 2012-02-24 |
ZA200802246B (en) | 2009-09-30 |
JP2009504686A (en) | 2009-02-05 |
RU2008110058A (en) | 2009-09-27 |
BRPI0614430A2 (en) | 2011-03-29 |
CA2619245A1 (en) | 2007-02-22 |
ZA200802247B (en) | 2009-08-26 |
NO20080800L (en) | 2008-05-09 |
CN101287763A (en) | 2008-10-15 |
EP1945669A1 (en) | 2008-07-23 |
CN101287762A (en) | 2008-10-15 |
KR20080068005A (en) | 2008-07-22 |
AU2006281981A1 (en) | 2007-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008002161A (en) | Chimeric antibodies with new world primate regions. | |
WO2007019620A8 (en) | Engineered antibodies with new world primate framework regions | |
IL212949A0 (en) | Humanized anti-cd4 antibody capable of activating cd4+ cd25+ regulatory t celle | |
WO2007129895A3 (en) | Deimmunized antagonistic anti-human cd40 monoclonal antibody from the ch5d12 antibody | |
ATE452147T1 (en) | ANTIBODIES WITH CORRECTED CDR | |
WO2006096491A3 (en) | Anti-ctla-4 antibody compositions | |
NZ602294A (en) | Monoclonal antibodies against c-met | |
IL191217A (en) | Humanized monoclonal anti-il-17 antibodies | |
WO2006031653A3 (en) | Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates | |
WO2007008943A3 (en) | Optimized anti-ep-cam antibodies | |
WO2005069970A3 (en) | Antibody specificity transfer using minimal essential binding determinants | |
WO2007120334A3 (en) | Methods and compositions for targeting polyubiquitin | |
WO2008048970A8 (en) | Synthetic antibodies | |
EP1761566A4 (en) | Humanized anti-tag-72 monoclonal antibodies | |
HK1139697A1 (en) | Humanized anti-ngf antibodies | |
RS53120B (en) | Antagonistic human light-specific human monoclonal antibodies | |
WO2006039258A3 (en) | Human antibodies against parathyroid hormone | |
EP2000541A4 (en) | Humanized anti-cd20 monoclonal antibody | |
WO2007149932A3 (en) | Methods and compositions for targeting hepsin | |
WO2008052108A3 (en) | Methods for use in human-adapting monoclonal antibodies | |
WO2008110914A3 (en) | Methods for producing active scfv antibodies and libraries therefor | |
EP1922412A4 (en) | Humanized antibody conjugates and related methods, assays, reagents, and kits | |
WO2007002525A3 (en) | Tomoregulin antibodies and uses thereof | |
WO2007002096A3 (en) | Methods and compositions for targeting ifnar2 | |
UA98100C2 (en) | Humanized monoclonal antibody that binds and neutralizes human nogo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Change of company name or juridical status | ||
FA | Abandonment or withdrawal |